Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

3 Defensive Stocks to Buy for an Uncertain Interest Rate Environment

Here are three top defensive stocks long-term investors can buy in this current market, no matter which way interest rates are headed.

MARA Stock Alert: The Bull and Bear Case for Marathon Digital

Here's why investors in Marathon Digital may want to consider this Marathon stock analysis before buying or selling shares.

3 High-Octane Growth Stocks Not Slowing Down Any Time Soon

These high-octane growth stocks provide the kind of upside long-term investors should want from higher-risk bets.

Why Is 4D Molecular (FDMT) Stock Up 85% Today?

Investors in 4D Molecular Therapeutics and FDMT stock are seeing big gains today, as the stock surges 80% on positive trial results.

Why Is MorphoSys (MOR) Stock Up 50% Today?

News of a potential takeout bid for any company usually leads to a big surge. That's what investors are seeing today with MOR stock.